Byrn, Inc. is a Nevada corporation described as a dormant shell that historically developed healthcare knowledge solutions and medical analytics software to measure and improve clinical performance and outcomes.

# Byrn, Inc.

## Overview
Byrn, Inc. is a Nevada corporation formed to become an emerging healthcare knowledge solutions company. The company’s stated goal is to transform health and healthcare by developing a standard for measuring clinical performance and outcomes. It developed medical software with tools and analytics designed to reduce costs while improving clinical performance, outcomes, predictive insight, and evidence-based clinical processes.

## Current status
The company is described in filings as a dormant shell.

## Product and solution focus (historical)
- Healthcare knowledge solutions  
- Medical software with tools and analytics aimed at improving clinical performance and outcomes and reducing costs  
- Emphasis on predictive insight and evidence-based clinical processes

## Corporate history and key events
- April 2011: Formed in Nevada  
- August 10, 2011: Authorized share increase from 900,000,000 to 2,510,000,000; designated 2,500,000,000 common shares and 10,000,000 blank-check preferred shares  
- March 2013–December 26, 2019: Dormant period  
- December 27, 2019: Custodian Ventures, LLC (David Lazar) appointed as custodian  
- December 31, 2019: David Lazar becomes sole director and officer (President, Treasurer, Secretary)  
- April 5, 2020: Grant of 10,000,000 Series A preferred shares with super-voting rights (convertible into 21,000,000,000 common shares)  
- September 10, 2020: Certificate of Designation filed (250 conversion ratio per Series A share)  
- September 23, 2020: Series A shares transferred from Custodian to FiveT Capital Holding AG; FiveT becomes roughly 50.2% voting-rights holder; Lazar releases debts owed to him/the Seller  
- September 23, 2020: Existing director/officer resignations; Lazar ceases to be CEO, CFO, and other officer roles  
- November 24, 2020: 1-for-1,000 reverse split; authorized common shares reduced from 2,500,000,000 to 500,000,000  
- December 1, 2020: FINRA declares name change and reverse split effective  
- November 24, 2020: Name change to Born, Inc. (in anticipation of new business operations)  
- February 2, 2021: Fiscal year-end changed to December 31  
- February 16, 2021: Share exchange with Alkeon Creators, Inc. (UK) exchanging 100% of Alkeon for 406,646,919 Byrn shares; transaction treated as a recapitalization with Alkeon as accounting acquirer; post-transaction outstanding shares 409,353,807; authorized 500,000,000  
- February 2021: Recapitalization transaction voided and written off; company considered a dormant shell from February 2021 through July 2023  
- July 16, 2024: Name changed to Byrn, Inc.

## Historical business focus
Historically described as a holding company that specialized in digital, data-led solutions to digitize retail supply chains and reimagine discovery and transactions online.

## Legal and regulatory status
No pending legal proceedings were disclosed in the filing. The filing describes the company as a dormant shell that has undergone extensive corporate actions and name changes.

## Properties
Not applicable.

If you want, I can convert the corporate timeline into a concise table or create a short narrative focused on ownership and name changes.

Born, Inc. is an emerging healthcare technology company focusing on medical software solutions for clinical performance analytics, currently classified as a dormant shell with no active revenue generating operations.

# Born, Inc. Overview

### Corporate Background
Born, Inc., formerly known as Quture International, Inc., is a Nevada corporation established in April 2011. The company aims to serve as an emerging healthcare knowledge solution provider, focusing on enhancing health and healthcare through innovative medical software. The software developed is designed to measure clinical performance and outcomes, thereby reducing costs while improving predictive insights and best clinical practices.

### Business Operations
- **Core Offering**: 
  - The company specializes in the development of medical software that provides tools and analytics for healthcare organizations. The goal is to transform healthcare metrics into actionable insights.
  
### Current Status
- **Operational Status**: As of the latest reporting period, Born, Inc. is classified as a dormant shell company. It does not have active operations, revenue generation, or significant ongoing business activities.
  
- **Business Model**: Born, Inc. intends to explore and identify business opportunities in the U.S., potentially engaging in acquisitions through reverse mergers or asset purchases. Management is in the process of developing a comprehensive business plan to reinvigorate the company.

### Financial Information (As of Latest Reporting)
- **Employees**: The number of employees is not disclosed, and the company primarily relies on consultants and external services.
  
- **Customers**: Specific details regarding the number of customers or client engagements are not available. The company appears to primarily focus on improving its business and strategic development instead of immediate client acquisition.

- **Revenue**: As of the end of the latest fiscal year, Born, Inc. reported no revenue, reflecting its status as a dormant shell.

- **Income/Loss**: The company reported a net loss of $21,221 for the year ended December 31, 2023. For the previous year (2022), the net loss was $4,752. This trend indicates ongoing operational challenges and a lack of revenue-generating activities.

### Summary
In conclusion, Born, Inc. is positioned as a healthcare technology firm with potential offerings in clinical performance analytics. However, as of the latest reports, it operates as a dormant entity, lacking customers and employees while facing financial losses. The management's plan focuses on resuming business operations through strategic acquisitions and partnerships in the healthcare sector.

Born, Inc. is a dormant shell company that originally developed healthcare analytics and medical software and later described itself as a holding company for digital, data-led retail supply-chain and online discovery solutions.

# Born, Inc. — Summary

## Business description
- Born, Inc. (f/k/a Quture International, Inc.; “Born”, “we”, “us”, or the “Company”) was created as an emerging healthcare knowledge-solution company that developed medical software, tools, and analytics intended to:
  - measure clinical performance and outcomes,
  - reduce costs while improving clinical performance and outcomes,
  - provide predictive insight and evidence-based clinical processes.
- At a later stage the Company is described as a holding company that specialized in digital, data-led solutions to digitize retail supply chains and reimagine online discovery and transactions.
- Current status in the provided text: Born, Inc. is a dormant shell company.

## Key corporate events / timeline (selected)
- April 2011: Company formed (Nevada corporation).
- August 10, 2011: Stockholders approved amendment increasing authorized shares from 900,000,000 to 2,510,000,000 (2,500,000,000 common; 10,000,000 blank-check preferred).
- March 22, 2013 – December 26, 2019: Company was dormant.
- December 27, 2019: Custodian Ventures, LLC (controlled by David Lazar) appointed custodian by Nevada Court.
- December 31, 2019: David Lazar became sole director and officer (also President, Treasurer, Secretary).
- April 5, 2020: Company granted David Lazar 10,000,000 preferred shares with super-voting rights (equivalent noted as 21,000,000,000 common shares in the text); each preferred share convertible into 250 common shares.
- September 10, 2020: Certificate of Designation filed changing conversion/voting rights of Series A preferred to 250 common shares per Series A share.
- September 23, 2020: 10,000,000 Series A preferred shares transferred from Custodian Ventures, LLC to FiveT Capital Holding AG; purchaser became ~50.2% voting holder on a fully-diluted basis and controlling shareholder. David Lazar released the Company from debts owed to him/the Seller. Existing director/officer resigned.
- November 24, 2020: Articles amended to change name from Quture International, Inc. to Born, Inc.; reverse split of common stock at 1-for-1,000; authorized common shares reduced from 2,500,000,000 to 500,000,000.
- December 1, 2020: FINRA declared the name change and reverse split effective.
- February 2, 2021: Fiscal year end changed to December 31.
- February 16, 2021: Share Exchange Agreement with Alkeon Creators, Inc. — 100% ownership of Alkeon exchanged for 406,646,919 shares of Born; former Alkeon stockholders became majority holders. The transaction was accounted for as a recapitalization where Alkeon was the accounting acquirer.
- February 2021: The transaction with Alkeon was voided and written off; Company considered a dormant shell from February 2021 through July 2023.
- July 2023: Company again went into custodianship with Custodian Ventures (per the provided text).

## Capital structure notes (from the provided text)
- Authorized common shares were increased historically (2011) and later reduced to 500,000,000 following the November 24, 2020 amendment.
- Series A Convertible Preferred Stock: 10,000,000 issued/granted (April 2020), with conversion changed to 250 common shares per preferred share (September 2020).
- After the February 16, 2021 share exchange (later voided), immediately post-closing the Company had 409,353,807 issued and outstanding shares.

## Legal / operational status
- The Company reports no pending legal proceedings involving the Company or its specified insiders (as stated).
- The Company describes itself in the supplied text as a dormant shell company.

## Information not provided in the supplied text
- Number of customers: not stated.
- Number of employees: not stated.
- Revenue: not stated.
- Net income (or loss): not stated.

(Only facts contained in the provided text have been summarized; no assumptions or hypotheticals were added.)

Byrn, Inc.

10-K / April 2, 2026

10-K / January 6, 2025

10-K / December 30, 2024

10-K / April 2, 2026

Byrn, Inc.

Overview

Current status

Product and solution focus (historical)

Corporate history and key events

Historical business focus

Legal and regulatory status

Properties